MX2007002899A - Composicion farmaceutica que comprende un isomero de un agente betamimetico y un agente anti-colinergico. - Google Patents
Composicion farmaceutica que comprende un isomero de un agente betamimetico y un agente anti-colinergico.Info
- Publication number
- MX2007002899A MX2007002899A MX2007002899A MX2007002899A MX2007002899A MX 2007002899 A MX2007002899 A MX 2007002899A MX 2007002899 A MX2007002899 A MX 2007002899A MX 2007002899 A MX2007002899 A MX 2007002899A MX 2007002899 A MX2007002899 A MX 2007002899A
- Authority
- MX
- Mexico
- Prior art keywords
- agent
- isomer
- pharmaceutical composition
- betamimetic
- cholinergic
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title abstract 3
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title abstract 2
- 230000003454 betamimetic effect Effects 0.000 title abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- NDAUXUAQIAJITI-LBPRGKRZSA-N (R)-salbutamol Chemical compound CC(C)(C)NC[C@H](O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-LBPRGKRZSA-N 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 229960001361 ipratropium bromide Drugs 0.000 abstract 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe una composicion farmaceutica en una forma de dosis adecuada para la inhalacion, que comprende un isomero terapeuticamente aceptable de una gente betamimetico o una sal, solvato, ester, derivo o polimorfo del mismo, sustancialmente libre de los isomeros terapeuticamente menos efectivos del agente, y opcionalmente un agente anti-colinergico o una sal, solvato, ester, derivado, isomero o polimorfo del mismo. Una composicion preferida comprende sulfato de R-salbutamol y bromuro de ipratropium. Son tambien proporcionados los metodos para elaborar las composiciones de la invencion.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN970MU2004 | 2004-09-09 | ||
| IN1004MU2004 | 2004-09-17 | ||
| IN1077MU2004 | 2004-10-08 | ||
| IN1089MU2004 | 2004-10-11 | ||
| IN1088MU2004 | 2004-10-11 | ||
| IN93MU2005 | 2005-01-31 | ||
| IN222MU2005 | 2005-02-28 | ||
| PCT/GB2005/003475 WO2006027595A1 (en) | 2004-09-09 | 2005-09-09 | Pharmaceutical composition comprising an isomer of a betamimetic agent and an anti-cholinergic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007002899A true MX2007002899A (es) | 2007-05-16 |
Family
ID=35311711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007002899A MX2007002899A (es) | 2004-09-09 | 2005-09-09 | Composicion farmaceutica que comprende un isomero de un agente betamimetico y un agente anti-colinergico. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070264202A1 (es) |
| EP (1) | EP1791534A1 (es) |
| JP (1) | JP2008512434A (es) |
| KR (1) | KR20070102659A (es) |
| AU (1) | AU2005281511B2 (es) |
| BR (1) | BRPI0515103A (es) |
| CA (1) | CA2580019A1 (es) |
| EA (1) | EA200700600A1 (es) |
| IL (1) | IL181828A0 (es) |
| MX (1) | MX2007002899A (es) |
| WO (1) | WO2006027595A1 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
| EP2026785A1 (de) | 2006-05-19 | 2009-02-25 | Boehringer Ingelheim International GmbH | Treibgasfreie aerosolformulierung für die inhalation enthaltend ipratropiumbromid und salbutamolsulfat |
| WO2007134965A1 (de) * | 2006-05-19 | 2007-11-29 | Boehringer Ingelheim International Gmbh | Aerosolformulierung enthaltend ipratropiumbromid und salbutamolsulfat |
| US20070286814A1 (en) * | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| JP2012506860A (ja) * | 2008-10-23 | 2012-03-22 | サノビオン ファーマシューティカルズ インク | アルホルモテロール及びチオトロピウムの組成物及びその使用方法 |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| EP3508239B1 (de) | 2009-05-18 | 2020-12-23 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| UA107097C2 (en) | 2009-11-25 | 2014-11-25 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Dispenser |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
| UA121114C2 (uk) | 2014-05-07 | 2020-04-10 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Небулайзер, індикаторний пристрій і контейнер |
| ES2874029T3 (es) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizador |
| ES2954961T3 (es) | 2014-05-07 | 2023-11-27 | Boehringer Ingelheim Int | Unidad, nebulizador y método |
| EP3569221A1 (en) * | 2018-05-17 | 2019-11-20 | Notoxins IP B.V. | Aqueous formulations comprising ipratropium for topical treatment of hyperhidrosis |
| CN113018280A (zh) * | 2021-03-01 | 2021-06-25 | 石家庄四药有限公司 | 一种异丙托溴铵吸入用溶液制剂及其制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
| US5919827A (en) * | 1990-07-11 | 1999-07-06 | Sepracor Inc. | Method for treating asthma using optically pure R(-) salmeterol |
| US6299863B1 (en) * | 1992-04-03 | 2001-10-09 | Sepracor Inc. | Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy |
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| US6423298B2 (en) * | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
| GB9827200D0 (en) * | 1998-12-11 | 1999-02-03 | Glaxo Group Ltd | Dry powder inhaler |
| WO2001064274A2 (en) * | 2000-03-01 | 2001-09-07 | Glaxo Group Limited | Metered dose inhaler |
| GB0009607D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical compositions |
| US20040019025A1 (en) * | 2000-04-18 | 2004-01-29 | Gavin Brian Charles | Medical compositions comprising (r,r)-formoterol and rofleponide |
| EP1311294A2 (en) * | 2000-08-04 | 2003-05-21 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
| WO2002034318A2 (en) * | 2000-10-20 | 2002-05-02 | Glaxo Group Limited | Inhaler |
| GB0030171D0 (en) * | 2000-12-11 | 2001-01-24 | Cipla Ltd | Process for preparing isomers of salbutamol |
| US20020189610A1 (en) * | 2001-02-01 | 2002-12-19 | Karl-Heinz Bozung | Pharmaceutical compositions containing an ipratropium salt and a betamimetic |
| GB0105560D0 (en) * | 2001-03-07 | 2001-04-25 | Glaxo Group Ltd | Pharmaceutical formulations |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| JP2003221335A (ja) * | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
| DK2292584T3 (en) * | 2002-12-10 | 2017-05-01 | Sunovion Pharmaceuticals Inc | Pharmaceutical composition comprising levalbuterol L-hemitartrate salt as aerosol formulation |
| US20040191176A1 (en) * | 2003-03-28 | 2004-09-30 | Kaplan Leonard W | Formulations for treatment of pulmonary disorders |
-
2005
- 2005-09-09 WO PCT/GB2005/003475 patent/WO2006027595A1/en active Application Filing
- 2005-09-09 MX MX2007002899A patent/MX2007002899A/es not_active Application Discontinuation
- 2005-09-09 AU AU2005281511A patent/AU2005281511B2/en not_active Ceased
- 2005-09-09 BR BRPI0515103-1A patent/BRPI0515103A/pt not_active IP Right Cessation
- 2005-09-09 JP JP2007530766A patent/JP2008512434A/ja active Pending
- 2005-09-09 KR KR1020077008004A patent/KR20070102659A/ko not_active Application Discontinuation
- 2005-09-09 CA CA002580019A patent/CA2580019A1/en not_active Abandoned
- 2005-09-09 EP EP05786158A patent/EP1791534A1/en not_active Withdrawn
- 2005-09-09 EA EA200700600A patent/EA200700600A1/ru unknown
- 2005-09-09 US US11/574,902 patent/US20070264202A1/en not_active Abandoned
-
2007
- 2007-03-08 IL IL181828A patent/IL181828A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1791534A1 (en) | 2007-06-06 |
| EA200700600A1 (ru) | 2008-02-28 |
| JP2008512434A (ja) | 2008-04-24 |
| CA2580019A1 (en) | 2006-03-16 |
| AU2005281511A1 (en) | 2006-03-16 |
| AU2005281511B2 (en) | 2011-03-31 |
| BRPI0515103A (pt) | 2008-07-08 |
| IL181828A0 (en) | 2007-07-04 |
| US20070264202A1 (en) | 2007-11-15 |
| WO2006027595A1 (en) | 2006-03-16 |
| KR20070102659A (ko) | 2007-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007002899A (es) | Composicion farmaceutica que comprende un isomero de un agente betamimetico y un agente anti-colinergico. | |
| PL2054411T3 (pl) | Nowe związki, ich izomery lub ich farmaceutycznie dopuszczalne sole jako antagoniści receptora waniloidowego oraz zawierające je kompozycje farmaceutyczne | |
| WO2008010921A3 (en) | Modulators of pharmacokinetic properties of therapeutics | |
| IL173908A0 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| TW200613243A (en) | Novel compounds | |
| WO2005094810A3 (en) | Novel pharmaceutical compositions | |
| NZ600790A (en) | Combination therapy for copd | |
| UA109417C2 (uk) | ЗАМІЩЕНІ ПІПЕРИДИНИ, ЯКІ ПІДВИЩУЮТЬ АКТИВНІСТЬ p53, І ЇХ ЗАСТОСУВАННЯ | |
| WO2006135638A3 (en) | Tanaproget compositions containing ethinyl estradiol | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
| IL194871A (en) | Compound linking to bir iap site, intermediate compound, process for compound preparation, method for making acceptable pharmaceutical salt, pharmaceutical preparation and use of compound for drug production | |
| UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
| MX2012007375A (es) | 3-ceto-n-propargil 1-aminoindano. | |
| WO2008020040A3 (en) | 2,5-dihydroxybenzene compounds for the treatment of fibrosis | |
| IL193252A0 (en) | N-hydroxyacrylamide compounds | |
| WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
| RS53355B (en) | AEROSOL FORMULATION FOR COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASES) | |
| UA96414C2 (ru) | Комбинация ферохина и производного артемизинина для лечения малярии | |
| WO2009140341A3 (en) | Atorvastatin compositions | |
| TW200800984A (en) | New compounds | |
| WO2005070427A8 (en) | Compounds for the sustained reduction of body weight | |
| EP1784173A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING METABOLIC BONE DISEASES CONTAINING ALPHA-ARYLMETHOXYACRYLATE DERIVATIVES | |
| GEP20145999B (en) | Usage of composition comprising formoterol and beclometasone dipropionate for prevention and/or treatment of asthma exacerbation | |
| WO2008104852A3 (en) | Pharmaceutical compositions comprising adsorbate of fenofibrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |